Jason Amello
Director of Finance/CFO at TSCAN THERAPEUTICS, INC.
Net worth: 217 521 $ as of 2024-04-29
Profile
Mr. Jason A.
Amello, CPA, is a Chief Financial Officer & Treasurer at TScan Therapeutics, Inc. Mr. Amello was previously employed as a Chief Financial & Accounting Officer by Candel Therapeutics, Inc., a Chief Financial Officer by Saniona AB, an Independent Director by Acer Therapeutics, Inc., a Treasurer, Chief Financial & Accounting Officer by Akebia Therapeutics, Inc., a Chief Financial Officer, Treasurer & Executive VP by ZIOPHARM Oncology, Inc., a Chief Accounting Officer, Senior VP & Controller by Genzyme Corp., and a Senior Manager by Deloitte & Touche USA LLP.
He also served on the board at Opexa Therapeutics, Inc. and New England Baptist Hospital.
He received his undergraduate degree from Boston College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-14 | 30,854 ( 0.11% ) | 217 521 $ | 2024-04-29 |
Jason Amello active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director of Finance/CFO | 2024-01-28 |
Former positions of Jason Amello
| Companies | Position | End |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Director of Finance/CFO | 2024-01-11 |
| ACER THERAPEUTICS INC. | Director/Board Member | 2023-11-16 |
New England Baptist Hospital
 New England Baptist Hospital Hospital/Nursing ManagementHealth Services New England Baptist Hospital provides orthopedic surgery and the treatment of musculoskeletal diseases and disorders. Its services include orthopedics, general surgery, medical services, patient care services, and programs. The company was founded by Francis Fremont Whittier in 1893 and is headquartered in Boston, MA. | Director/Board Member | 2022-12-31 |
| SANA AB | Director of Finance/CFO | 2022-08-31 |
| AKEBIA THERAPEUTICS, INC. | Director of Finance/CFO | 2020-06-28 |
Training of Jason Amello
| Boston College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| SANA AB | Health Technology |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
New England Baptist Hospital
New England Baptist Hospital Hospital/Nursing ManagementHealth Services New England Baptist Hospital provides orthopedic surgery and the treatment of musculoskeletal diseases and disorders. Its services include orthopedics, general surgery, medical services, patient care services, and programs. The company was founded by Francis Fremont Whittier in 1893 and is headquartered in Boston, MA. | Health Services |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
Deloitte LLP (New York)
 Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Jason Amello
